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From Stanford University and Palo Alto Veterans Hospital, California, USA SUMMARY Although traditional teaching emphasises that 70-80% of patients with rheumatoid arthritis have positive serological tests for rheumatoid factor, a review of the evidence suggests that the seronegative group has distinctive characteristics. In a blinded and controlled evaluation of hand and wrist films we correctly identified the serological status of 43 out of 46 patients satisfying the ARA criteria for 'definite RA'. The radiographic appearances of the seronegative group differed significantly from those of the seropositive group in (1) degree of juxtalesional osteosclerosis (p<0001); (2) the relative absence of classical subchondral erosions (p<0 001); (3) presence of new bone formation (p<0 001); (4) more fusion (p<0001); (5) more asymmetrical joint involvement (p<0 001); and (6) predominant carpal involvement (p<0 001). The nature of the destructive process, as defined radiologically, may be different in patients with seropositive rheumatoid arthritis from that seen in individuals with so-called 'seronegative rheumatoid arthritis'.
The discovery of serum rheumatoid factor(s) and HLA B27 has done much to further our understanding of the nosology of the inflammatory arthropathies. The B27. related spondylarthropathies are now known to be distinct entities, and the old term rheumatoid variants is no longer applicable. However, there is still confusion about the nature of another seronegative group, 'seronegative RA'.' Table 1 outlines the classification of inflammatory arthropathies of unknown aetiology. These can be conveniently subdivided into 2 groups-the seropositive and seronegative. The division is somewhat arbitrary in that some diseases, for example, systemic lupus erythematosus (SLE), can Table 3 gives the percentages of the 16 seronegative and the 30 seropositive patients who had the 6 radiographic qualities listed above. The remaining 13 Fig. 2A showing right hand. Note asymmetrical wrist and MCP disease with partialfusion at the carpal-metacarpal and intracarpal joints. involvement in 6 out of 12 cases, only 6 % of the total seronegative group had all joint pairs symmetrically involved compared with 93% of the seropositive group (p<0 001).
The juxta-articular new bone formation characteristically occurred at the inferior radioulnar joint, although it was also seen at the MCP and distal interphalangeal (DIP) joints. Whereas Fig. 1A . It shows the cortical defects of classical erosions seen especially at the capsular insertion sites.
By contrast, joint destruction in the absence of classical erosions was the rule in 88 % of seronegative patients. Fig. 2A shows clear-cut obliteration of the joint space due to cartilage destruction but without the well-delineated erosions so typical of seropositive disease. Note that the only clear erosion is seen at the left inferior radioulnar joint and that it has a sclerotic border of fine new bone surrounding it. Fig. 2B is the right hand of the same seronegative patient showing asymmetrical wrist and MCP involvement as well as a marked degree of carpal fusion.
Figs. 3A and 3B show reactive new bone formation at the right inferior radioulnar joint and the right first MCP, as well as the asymmetrical pattern of destruction without erosions at the MCP joints. The wrists are symmetrically and predominantly involved, with almost total fusion bilaterally. There is also juxtaarticular sclerosis at the radiocarpal and MCP joints. Again there may be a single erosion at the distal end of the right radius, but this contrasts with an average of 12 erosions per film in the seropositive patients. and reactive new bone formation at the inferior radioulnar joint. The left wrist (Fig. 4B) is radiologically intact, emphasising the asymmetry at the wrists. Fig. 5 is similar to Figs. 4A , B in that it shows predominant carpal involvement that is asymmetrical. Note the absence of classical well-marginated erosions and the partial fusion of the right intracarpal bones.
Discussion
One of the most important prerequisites to performing comparative studies is to ensure the homogeneity of the patient population under consideration. Most modern studies of rheumatoid arthritis include patients with either definite or classical disease, but rarely are the results analysed according to the serological status. As we have argued elsewhere,' most 'seronegative rheumatoid arthritis' patients can meet only 5 ARA criteria, since nodules, erosion, and seropositivity are usually interdependent. Therefore these 'definite rheumatoid arthritis' patients may indeed be quite different from those patients with classical disease.
A review of the earlier literature corroborates the notion that persistently 'seronegative rheumatoid arthritis' may be distinct from seropositive disease. As early as 1959 Kellgren and Ball" reported on the clinical significance of a positive rheumatoid factor as determined by the sheep cell agglutination test (SCAT). By carefully re-evaluating the diagnoses of those patients with persistently seronegative disease and excluding others as alternate diagnoses became evident, they found that 96% of males and 92% of females with definite rheumatoid arthritis were seropositive, percentages which are higher than the often quoted 70-80% figure. '3 "4 Early family data '5 16 show that definite or classical rheumatoid arthritis occurs significantly more frequently in relatives of seropositive probands. By contrast, 'seronegative rheumatoid arthritis' appears not to be familial. There are equivalent data from twin studies showing concordance of disease only in the seropositive disorder. '6 Recent immunogenetic data may provide a clue to this familial clustering. HLA DR4 has been associated with seropositive rheumatoid arthritis in 50-60% of cases.'7 18 However, the frequency of DR4 in 'seronegative rheumatoid arthritis' patients is no different from that in control populations '8- The most important point is that, when there was radiographic change, seronegative disease could be distinguished from seropositive disease on the basis of 6 radiographic criteria. These differences suggest that a different pathogenetic mechanism may underly seronegative arthritis. Some radiographic changes are reminiscent of those seen in psoriatic arthritis; however, none of these patients had psoriasis for an average duration of 8-9 years. It is therefore difficult to conceptualise this group of patients as psoriatic arthritis sine psoriasis.
An interesting parallel might be drawn with the 30-40% of patients with juvenile chronic arthritis who are seronegative and DR4 negative. Could our 'seronegative rheumatoid arthritis' subset be the adult equivalent of this juvenile group? Unfortunately no long-term follow-up radiographic studies have been done on this subset of JCA patients to serve as a comparison group. Certain features in adult-onset Still's disease27 mimic those seen in our patients.
Until further comparative studies can be performed, we consider that the term seronegative polyarthritis should be used in place of 'seronegative rheumatoid arthritis'. This substitution will allow accurate long-term follow-up of this group of patients with regard to differential response to therapy, prognosis, and incidence of side effects. It will also facilitate more accurate basic research into the underlying pathogenesis of joint destruction, since the investigators will focus on patients who clearly have seropositive rheumatoid arthritis and separately on individuals who have seronegative disease, the majority of whom may not have 'seronegative definite rheumatoid arthritis'. 
